Found 4323 articles for: ""
Highlighting the Link Between Lichen Planus Pigmentosus and Frontal Fibrosing Alopecia
March 2024 | Volume 23 | Issue 3 | Features | 196 | Copyright © March 2024
Complementary and Alternative Medicine for Hidradenitis Suppurativa Discussed on TikTok: A Cross-Sectional Analysis
March 2024 | Volume 23 | Issue 3 | Editorials | e93 | Copyright © March 2024
Background: Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease that negatively affects patient quality of life, and conventional treatments are variabl...
Read MoreEfficacy of Low-Dose Spironolactone for Hair Loss in Women
March 2024 | Volume 23 | Issue 3 | Editorials | e91 | Copyright © March 2024
Microneedling for Treatment of Acne Scars: Considerations on the Successful Management of This Aesthetic Procedure
March 2024 | Volume 23 | Issue 3 | Editorials | e79 | Copyright © March 2024
Attenuation of Atopic Dermatitis in Newborns, Infants, and Children With Prescription Treatment and Ceramide-Containing Skin Care: A Systematic Literature Review and Consensus
March 2024 | Volume 23 | Issue 3 | Original Article | 152 | Copyright © March 2024
Background: Atopic dermatitis (AD) typically starts in infancy and early childhood. The chronic skin disorder is associated with recurrent flares, pruritus, and genetic predispos...
Read MoreSafety and Efficacy of Minoxidil Treatment in Scarring Alopecia: A Scoping Review
March 2024 | Volume 23 | Issue 3 | Original Article | 146 | Copyright © March 2024
Background: Topical minoxidil (TM) has been a cornerstone in treating various hair loss disorders, while low-dose oral minoxidil (LDOM) is emerging as an effective alternative. D...
Read MoreSurvey of the Prices of Topical Compounded Medications for Alopecia in the Tri-State Area
March 2024 | Volume 23 | Issue 3 | Original Article | 168 | Copyright © March 2024
Background: Currently, there is only one topical medication approved by the U.S. Food and Drug Administration for alopecia, minoxidil 2.5% and 5%. With limited options, dermatolo...
Read MoreSurvey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia
March 2024 | Volume 23 | Issue 3 | Original Article | 136 | Copyright © March 2024
Background: Utilization of low-dose oral minoxidil has increased in recent years in association with several clinical studies that have shown its efficacy in treating androgeneti...
Read MoreComparing Clinical Outcomes of Steroid-Sparing Therapy With Rituximab Versus Rituximab Alone in Pemphigus
March 2024 | Volume 23 | Issue 3 | Editorials | e97 | Copyright © March 2024
Background: Previous clinical trials have demonstrated that rituximab therapy combined with conventional steroid-sparing therapy (SST) has increased rates of disease control for ...
Read MorePemphigus Vulgaris Successfully Treated With Bromocriptine
March 2024 | Volume 23 | Issue 3 | Case Reports | e83 | Copyright © March 2024
Pemphigus vulgaris (PV) is an autoimmune blistering skin condition primarily treated with immunosuppressive agents. We describe a case of PV successfully treated with nonconventional treatment, b...
Read MoreNovel Clinical Applications of Topical Ruxolitinib: A Case Series
March 2024 | Volume 23 | Issue 3 | Case Reports | 188 | Copyright © March 2024
Topical ruxolitinib, a potent Janus kinase (JAK) inhibitor, has shown significant efficacy in treating inflammatory skin conditions. While its use has already been established in atopic dermatiti...
Read MoreExamining the Uncertainties Surrounding Exosome Therapy in Androgenetic Alopecia: A Call for Evidence-Based Practice
March 2024 | Volume 23 | Issue 3 | Features | e86 | Copyright © March 2024
Hair loss, a pervasive and often distressing condition, affects a substantial number of individuals globally. Although conventional treatments such as hair transplantation, topicals, oral medicat...
Read MoreUrticaria Pigmentosa Without Pruritus
March 2024 | Volume 23 | Issue 3 | Case Reports | e81 | Copyright © March 2024
Mastocytosis is a group of disorders characterized by the pathologic accumulation of mast cells in various tissues. One example of mastocytosis is urticaria pigmentosa, which presents with mastoc...
Read MoreEfficacy and Tolerability of Topical 0.1% Stabilized Bioactive Retinol for Photoaging: A Vehicle-Controlled Integrated Analysis
April 2024 | Volume 23 | Issue 4 | Original Article | 8124 | Copyright © April 2024
Read MoreFirst Use of Combination Oral Deucravacitinib With Tapinarof Cream for Treatment of Severe Plaque Psoriasis
March 2024 | Volume 23 | Issue 3 | Case Reports | 192 | Copyright © March 2024
Plaque psoriasis is a chronic, immune-mediated, cutaneous, and systemic inflammatory dermatosis. Its pathogenesis involves the dysregulation of the interleukin (IL)-23/IL-17 signaling pathway. Th...
Read MoreINDIVIDUAL ARTICLE: Antibiotic Stewardship in Acne: 2023 Update
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF378969s4 | Copyright © February 2024
Antibiotics, topical and oral, are a cornerstone in the treatment of acnes vulgaris specifically by targeting the skin bacterium Cutibacterium acnes. Billions of individuals have received antibio...
Read MoreFULL SUPPLEMENT: Looking Beyond the Skin, Examining the Patient and Clinician Reported Outcomes and Effects of Acne Vulgaris and Sarecycline Treatment
February 2024 | Volume 23 | Issue 2 | Department | SF405634s1 | Copyright © February 2024
Background: Concise patient-reported outcome (PRO) instruments addressing the consequences of facial acne vulgaris (AV) on patients' functioning and activities of daily living (A...
Read MoreFULL SUPPLEMENT: Updating Antibiotic Use for Acne Management in 2023
February 2024 | Volume 23 | Issue 2 | Department | SF378969s1 | Copyright © February 2024
Antibiotics, topical and oral, are a cornerstone in the treatment of acnes vulgaris specifically by targeting the skin bacterium Cutibacterium acnes. Billions of individuals have received antibio...
Read MoreINDIVIDUAL ARTICLE: Vehicles Matter!
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF378969s3 | Copyright © February 2024
INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s12 | Copyright © February 2024
Media and other results for: ""